Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. As a result, the website is experiencing intermittent interruptions. We're aware of this issue and we're working to resolve these issues. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Skip subpage navigation

COVID-19

COVID-19 Vaccine Resource Center for Health Care Personnel

COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), is a single-stranded RNA virus that belongs to the large family Coronaviridae.

COVID-19 was declared a pandemic in March 2020. The COVID-19 pandemic has caused substantial morbidity and mortality, as well as social and economic disruption worldwide.

SARS-CoV-2 is transmitted from person-to-person by airborne particles and droplets. Infection from contaminated surfaces or objects is also possible but a less common source of illness. People with COVID-19 can be infectious from 1–2 days before, and up to 8–10 days after, symptoms begin.

Symptoms of COVID-19 may include fever, sore throat, congestion, cough, headache, body aches, fatigue, and/or loss of taste and smell. Severe disease may include pneumonia, cardiac complications, neurologic complications, and/or blood clotting problems. Risk of severe COVID-19 illness or death is higher in older persons, patients who are immunocompromised, or persons who have other underlying medical conditions.

Vaccines to prevent COVID-19 became available in December 2020. COVID-19 vaccine recommendations change over time, as vaccines are updated to better target evolving variants of SARS-CoV-2 viruses.

Note: FDA and CDC have approved and recommended updated 2024-2025 COVID-19 vaccine formulation. Older formulations of COVID-19 vaccines are no longer authorized for use in the United States.

Resource Center

You will find below all of the resources you will need about the COVID-19 vaccine. More will be added as they are published or released.

Forms Date
DD Form 3111: Routine Immunization Screening Form: Adult
March 2020
DD Form 3110: Routine Immunization Screening Form: Pediatric
March 2020
DHA Form 177, Potentially Compromised Temperature Sensitive Medical Product Worksheet
July 2024
U.S. Department of Health and Human Services Vaccine Adverse Event Reporting System (VAERS) form
July 2024
Standing Orders Date
Standing Orders for Administering COVID-19 Vaccine (Pediatric) (Right-click and save this document to your desktop in order to fill it out and add digital signature)
Oct. 20, 2023
Standing Orders for Administering COVID-19 Vaccine (Adult) (Right-click and save this document to your desktop in order to fill it out and add digital signature)
Oct. 20, 2023
Information Paper Date
COVID-19 Disease and COVID-19 Vaccine Aug. 23, 2024
Vaccine Information Statement Date
COVID-19 Vaccine: What You Need to Know Oct. 19, 2023
Manufacturer Package Inserts Date
COMIRNATY (Pfizer-BioNTech) COVID-19 Vaccine (This vaccine is licensed for use in people 12 and older)
Aug. 22, 2024
SPIKEVAX (Moderna) COVID-19 Vaccine (This vaccine is licensed for use in people 12 and older)
Aug. 22, 2024
Emergency Use Authorization Fact Sheets Date
Novavax
Fact Sheet for Recipients and Caregivers about Novavax COVID-19 Vaccine Oct. 3, 2023
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Novavax COVID-19 Vaccine
Oct. 3, 2023
Pifzer-BioNTech
Fact Sheet for Recipients and Caregivers about Pfizer-BioNTech COVID-19 Vaccine (2024-2025 formulation) Aug. 22, 2024
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Pfizer-BioNTech COVID-19 Vaccine (2024-2025 formulation) Aug. 22, 2024
Moderna
Fact Sheet for Recipients and Caregivers about Moderna COVID-19 Vaccine (2024-2025 formulation) 
Aug. 22, 2024
Fact Sheet for Healthcare Providers Administering Vaccine: Emergency Use Authorization of Moderna COVID-19 Vaccine (2024-2025 formulation)
Aug. 22, 2024
Clinical Considerations Date
Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States Aug. 23, 2024
Vaccine Product Information Date
U.S. COVID-19 Vaccine Product Information
March 19, 2024
Vaccine Storage and Handling Resources Date
Pfizer-BioNTech
Vaccine Summary At A Glance
March 15, 2024
Vaccine Storage and Beyond-Use Date Tracking Labels
Jan. 22, 2024
Transporting Vaccine for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations
May 2, 2023
Vaccine Expiration Date Tracking Tool
Jan. 7, 2021
Moderna
Vaccine Summary At A Glance March 19, 2024
Vaccine Storage and Beyond-Use Date Tracking Labels
Oct. 17, 2023
Vaccine Expiration Date Tracking Tool
Jan. 7, 2021
Novavax
Vaccine Summary At A Glance March 14, 2024
Vaccine Storage and Beyond-Use Date Tracking Labels
Dec. 1, 2023
Temperature Log when Transporting Vaccine at Refrigerated Temperatures
Feb. 18, 2021
Vaccine Expiration Date Tracking Tool
Jan. 7, 2021
Adverse Events Date
DOD Clinical Guidelines for Post-Vaccination Associated Myopericarditis, Version 13
February 2024
Adverse Events for Healthcare Providers webpage
Nov. 8, 2023
Vaccine Safety Date
v-safe After Vaccination Health Checker Information Sheet (CDC) Aug. 8, 2024
Advisory Committee on Immunization Practices Recommendations Date
COVID-19 Vaccine July 25, 2024
Resources for Building Vaccine Confidence
Building Vaccine Confidence in Health Systems and Clinics
June 2021
Patient Education Resources Date
COVID-19 Vaccine Frequently Asked Questions
July 3, 2024

You also may be interested in...

Skip subpage navigation
Last Updated: August 28, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery